The Advisory Board Company to Highlight New Technology Capabilities that Support Accountable Care

WASHINGTON, May 31, 2012 /PRNewswire/ -- The Advisory Board Company will describe its innovative use of health care data and introduce new technology capabilities to support Accountable Care Organizations at the Health Data Initiative (HDI) Forum III, also known as the Health Datapalooza, on June 5-6 at the Washington Convention Center. 

(Logo: http://photos.prnewswire.com/prnh/20110802/PH45999LOGO )

"We are excited to be among the diverse group of health care and technology leaders that is coming together to support health care data innovations at the third annual Health Datapalooza," said Aneesh Chopra, former U.S. Chief Technology Officer and current Senior Advisor, Health Care Technology Strategy at The Advisory Board Company.  Mr. Chopra, who will attend the HDI Forum, added, "In the shift toward an accountable care payment landscape, The Advisory Board Company is at the forefront in helping hospitals and health systems improve quality, control costs, and optimize health care utilization through centralized population risk management.  We look forward to inspiring discussion and new innovative solutions to improve our nation's health care system." 

Matt Cinque, Managing Director of Performance Technologies at The Advisory Board Company, will join Atul Gawande and others at a breakout presentation at the HDI Forum entitled "Accountable Care Organizations: Using Data to Deliver Patient-Centered Care and Improve Population Health While Lowering Costs," in Room 103A from 1:30-4:30 pm EDT on Wednesday, June 6. 

Mr. Cinque's presentation will highlight new functionality from The Advisory Board Company's Crimson (R) program that connects sophisticated population analytics with direct patient care.  Specifically, the presentation will explain how leading hospitals and health systems can use Crimson to identify high-risk patients and support active and coordinated care management for these individuals, including at the point of care.  By bringing together leading-edge analytic and workflow technologies developed in partnership with Milliman MedInsight and the University of Michigan, Crimson helps provider organizations secure new needed capabilities and bridge the often-siloed worlds of analysis and action. 

"Payers have had solid population risk analytics for years," Mr. Cinque said, "but they have been unable to meaningfully inflect patient care and outcomes.  Providers have a better chance of moving the dial, but only if they're able to connect these analytics to patient-level decisions and coordination.  Crimson now offers hospitals and health systems that opportunity." 

The session will include a reactor panel of Accountable Care Organizations and experts who will discuss the impact and value of Crimson.

In addition to the June 6 presentation, Mr. Cinque will provide insights from the firm's experiences impactfully leveraging CMS data.  This discussion will be part of a breakout panel session entitled "How to Turn Data into Meaningful Information for Business Problems; Strategy, Practice and Games for Start Ups and Status Quos with Examples from CMS Data,"  in Room 101 from 1:30-5:30 pm EDT on Tuesday, June 5

Across the country, health care providers are utilizing The Advisory Board Company's Crimson suite of products, including a cohort focused specifically on leveraging Crimson to manage population risk more effectively.  "Crimson services have played a strategic role in our ability to structure risk-based contracts with payers," said Charles Kelly, D.O., President and CEO, Henry Ford Physician Network, a physician-led subsidiary of Henry Ford Health System that focuses on delivering higher quality care while reducing medical costs through collaborative best practices, evidence-based medicine and improved efficiency.  "Crimson has enabled us to understand and improve our performance on controlled populations and has given us the confidence to pursue additional risk-based contracts."  

The Advisory Board Company is a global technology, research, and consulting firm partnering with 140,000 leaders in 3,700 organizations across health care and higher education.  Through its Crimson offerings, The Advisory Board Company collaborates with health care providers dedicated to strengthening hospital-physician alignment, coordination among care settings, and overall clinical performance. 

For more information on Crimson and managing population risk, visit The Advisory Board Company's booth No. 2 (West Salon) at the HDI Forum or see the firm's Web resources for managing population risk at http://www.advisory.com/Technology/Crimson-Population-Risk-Management. 

About The Advisory Board Company 

The Advisory Board Company is a global technology, research, and consulting firm partnering with 140,000 leaders in 3,700 organizations across health care and higher education.  Through its innovative membership model, The Advisory Board Company collaborates with executives and their teams to elevate performance and solve their most pressing challenges.  The company provides strategic guidance, actionable insights, web-based software solutions, and comprehensive implementation and management services.  Through its Crimson offerings, The Advisory Board Company collaborates with health care providers dedicated to strengthening hospital-physician alignment, coordination among care settings, and overall clinical performance.  Combining business intelligence technology with best practice implementation, Crimson offerings are developed with hospitals, health systems, physicians, and other practitioners seeking improved alignment on key clinical, operational and strategic goals.  For more information about The Advisory Board Company, visit http://www.advisory.com.

SOURCE The Advisory Board Company